01—Abstract
Summary
Summary of the 10-K filed March 2, 2026. Cited figures are marked; the original filing is the authoritative source.
UNITEDHEALTH GROUP INC. (UNH) reported its 2025 fiscal year results, highlighting continued revenue growth across its segments, particularly in UnitedHealthcare and Optum Rx.
Despite a strong top-line performance, the company's earnings from operations saw a significant decline of 41% compared to the prior year. This decrease was primarily attributed to elevated medical cost trends, which outpaced pricing assumptions, and the impact of restructuring and other actions totaling $2.5 billiona. Key areas impacting profitability include increased medical costs driven by higher care activity, provider pricing, and the effects of the Inflation Reduction Act on Medicare Part D plans.
UnitedHealthcare experienced a 16%b revenue increase, driven by Medicare Advantage and fee-based commercial offerings, but its earnings from operations fell by 40% due to the aforementioned cost pressures and specific business adjustments. Optum, while growing revenues by 7%, saw its earnings from operations decrease by 43%, largely due to challenges within Optum Health, which reported a net loss from operations. This segment was impacted by Medicare Advantage funding reductions and medical cost trends.
Optum Rx, however, demonstrated strong performance with a 16%c revenue increase and a 23% rise in earnings from operations, benefiting from higher script volumes and a gain on a business deconsolidation. The company also managed its capital effectively, with significant cash flows from operations and a robust balance sheet, while continuing to return capital to shareholders through dividends and share repurchases.
02—Key points
Key Highlights
- Total revenues increased by 12% to $447.6 billion, driven by strong performance in UnitedHealthcare (+16%) and Optum Rx (+16%).
- Earnings from operations decreased significantly by 41% to $19.0 billion, primarily due to elevated medical cost trends and restructuring charges.
- UnitedHealthcare segment saw revenue growth of 16% but a 40% decline in earnings from operations, impacted by medical cost pressures and Medicare Advantage funding.
- Optum Health reported a net loss from operations (-$0.3 billion) and a significant decline in operating margin, affected by Medicare funding reductions and increased medical costs.
- Optum Rx showed robust growth, with revenues up 16% and earnings from operations up 23%, benefiting from increased script volumes and portfolio gains.
- The company provided substantial support to care providers impacted by the Change Healthcare cyberattack, including increasing reserves for provider loans by $799 million.
- UnitedHealth Group continues to return capital to shareholders, increasing its quarterly cash dividend and maintaining its share repurchase program, with $21 million shares remaining available for repurchase as of December 31, 2025.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in FY2025, UnitedHealth Group Inc kept $0.03.
- Revenue$447.57B100.0%
- Cost of revenue−$50.66B11.3%
- Gross profit$396.91B88.7%
- Operating costs−$377.95B84.4%
- Operating income$18.96B4.2%
- Interest, other & tax−$6.91B1.5%
- Net income$12.06B2.7%
Where FY2025 revenue went
$447.57B- Other operating costs: $318.36B, 71% of revenue
- SG&A: $59.59B, 13% of revenue
- Net income: $12.06B, 2.7% of revenue
- Cost of revenue: $50.66B, 11% of revenue
- Interest, other & tax: $6.91B, 1.5% of revenue
Kept 2.7% as net incomeNet income $12.06B · 2.7%Interest, other & tax $6.91B · 1.5%
Full revenue history →04—Financials
Financial Highlights
Figures from 10-KFY2025filed March 2, 2026Financial Statements
FY2025 against FY2024
| Line item | FY2025FY2024 | Change |
|---|---|---|
| Revenue | $447.57B$400.28B | +11.8% |
| Cost of Revenue | $50.66B$46.69B | +8.5% |
| Gross Profit | $396.91B$353.58B | +12.3% |
| SG&A Expenses | $59.59B$53.01B | +12.4% |
| Operating Expenses | $428.60B$367.99B | +16.5% |
| Operating Income | $18.96B$32.29B | −41.3% |
| Interest Expense | $4.00B$3.91B | +2.5% |
| Net Income | $12.06B$14.40B | −16.3% |
| EPS (Basic) | $13.28$15.64 | −15.1% |
| EPS (Diluted) | $13.23$15.51 | −14.7% |
| Shares Outstanding (Basic) | 908.00M921.00M | −1.4% |
| Shares Outstanding (Diluted) | 911.00M929.00M | −1.9% |
05—Questions
Frequently Asked Questions
What were the main drivers behind the significant decrease in UnitedHealth Group's earnings from operations in 2025?
The primary reasons for the 41% decrease in earnings from operations were elevated medical cost trends that outpaced pricing assumptions, a $2.5 billion impact from restructuring and other actions, and the effects of the Inflation Reduction Act on Medicare Part D plans. These factors, combined with increased care activity and provider pricing, led to higher medical costs across the company.
How did the Medicare Advantage business perform in 2025, and what is the outlook?
UnitedHealthcare Medicare & Retirement revenues increased by 23% driven by growth in people served. However, earnings from operations within the broader UnitedHealthcare segment declined due to Medicare Advantage funding reductions and elevated medical cost trends. The company anticipates its Medicare Advantage membership will contract in 2026 due to continued funding pressures and adjustments made to benefit and pricing strategies.
What is the impact of the Change Healthcare cyberattack on the company's financial results?
The company provided significant support to care providers affected by the Change Healthcare cyberattack, which occurred in February 2024. In Q4 2025, UnitedHealth Group increased its reserves for net collection expectations related to provider loans and other customer balances by $799 million, primarily impacting Optum Insight. While there were incremental medical costs for accommodations made to care providers in 2024, the overall impact on 2025 results was lower compared to the previous year, partly due to these reserve adjustments.
How is Optum Health performing, and what are the key challenges?
Optum Health's revenues decreased slightly, and it reported a net loss from operations in 2025. The segment was negatively impacted by Medicare Advantage funding reductions, continued medical cost trend pressures, and changes in the member profile for value-based care arrangements. The company also established a loss contract reserve of $623 million related to anticipated future losses in 2026 for certain value-based care businesses.
06—Continue